110 related articles for article (PubMed ID: 23632409)
21. Controlled release of ethacrynic acid from poly(lactide-co-glycolide) films for glaucoma treatment.
Wang Y; Challa P; Epstein DL; Yuan F
Biomaterials; 2004 Aug; 25(18):4279-85. PubMed ID: 15046918
[TBL] [Abstract][Full Text] [Related]
22. Comparison of single thickness and double thickness processed pericardium patch graft in glaucoma drainage device surgery: a single surgeon comparison of outcome.
Lankaranian D; Reis R; Henderer JD; Choe S; Moster MR
J Glaucoma; 2008; 17(1):48-51. PubMed ID: 18303385
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of adjunctive mitomycin C during Ahmed Glaucoma Valve implantation: a prospective randomized clinical trial.
Costa VP; Azuara-Blanco A; Netland PA; Lesk MR; Arcieri ES
Ophthalmology; 2004 Jun; 111(6):1071-6. PubMed ID: 15177955
[TBL] [Abstract][Full Text] [Related]
24. Two-year survival of Ahmed valve implantation in the first 2 years of life with and without intraoperative mitomycin-C.
Al-Mobarak F; Khan AO
Ophthalmology; 2009 Oct; 116(10):1862-5. PubMed ID: 19592105
[TBL] [Abstract][Full Text] [Related]
25. Nanostructured medical device coatings based on self-assembled poly(lactic-co-glycolic acid) nanoparticles.
Dayyoub E; Hobler C; Nonnweiler P; Keusgen M; Bakowsky U
Mater Sci Eng C Mater Biol Appl; 2013 Jul; 33(5):3018-24. PubMed ID: 23623127
[TBL] [Abstract][Full Text] [Related]
26. Long-term outcomes of needle revision of trabeculectomy blebs with mitomycin C and 5-fluorouracil: a comparative safety and efficacy report.
Anand N; Khan A
J Glaucoma; 2009 Sep; 18(7):513-20. PubMed ID: 19223788
[TBL] [Abstract][Full Text] [Related]
27. The case against glaucoma drainage implant surgery in patients with a poor prognosis for standard filtering procedure.
Higginbotham EJ
Arch Ophthalmol; 2004 Jan; 122(1):105-7. PubMed ID: 14718305
[No Abstract] [Full Text] [Related]
28. Comparison of low-dose intraoperative mitomycin-C vs 5-fluorouracil in primary glaucoma surgery: a pilot study.
Vijaya L; Mukhesh BN; Shantha B; Ramalingam S; Sathi Devi AV
Ophthalmic Surg Lasers; 2000; 31(1):24-30. PubMed ID: 10976557
[TBL] [Abstract][Full Text] [Related]
29. Porous hydroxyapatite scaffold with three-dimensional localized drug delivery system using biodegradable microspheres.
Son JS; Appleford M; Ong JL; Wenke JC; Kim JM; Choi SH; Oh DS
J Control Release; 2011 Jul; 153(2):133-40. PubMed ID: 21420453
[TBL] [Abstract][Full Text] [Related]
30. Controlled-release implant system formulated using biodegradable hemostatic gauze as scaffold.
Xu L; Wu F; Yuan W; Jin T
Int J Pharm; 2008 May; 355(1-2):249-58. PubMed ID: 18249510
[TBL] [Abstract][Full Text] [Related]
31. [Mitomycin C in glaucoma surgery].
Collignon-Brach J
Bull Soc Belge Ophtalmol; 1993; 247(1):79-86. PubMed ID: 8205344
[TBL] [Abstract][Full Text] [Related]
32. An in vitro study of plasticized poly(lactic-co-glycolic acid) films as possible guided tissue regeneration membranes: material properties and drug release kinetics.
Owen GR; Jackson JK; Chehroudi B; Brunette DM; Burt HM
J Biomed Mater Res A; 2010 Dec; 95(3):857-69. PubMed ID: 20824651
[TBL] [Abstract][Full Text] [Related]
33. Target drug delivery system as a new scarring modulation after glaucoma filtration surgery.
Shao T; Li X; Ge J
Diagn Pathol; 2011 Jul; 6():64. PubMed ID: 21736763
[TBL] [Abstract][Full Text] [Related]
34. Comparison of mitomycin C trabeculectomy, glaucoma drainage device implantation, and laser neodymium:YAG cyclophotocoagulation in the management of intractable glaucoma after penetrating keratoplasty.
Ayyala RS; Pieroth L; Vinals AF; Goldstein MH; Schuman JS; Netland PA; Dreyer EB; Cooper ML; Mattox C; Frangie JP; Wu HK; Zurakowski D
Ophthalmology; 1998 Aug; 105(8):1550-6. PubMed ID: 9709773
[TBL] [Abstract][Full Text] [Related]
35. Mitomycin C and 5-fluorouracil antimetabolite therapy for pediatric glaucoma filtration surgery.
Snir M; Lusky M; Shalev B; Gaton D; Weinberger D
Ophthalmic Surg Lasers; 2000; 31(1):31-7. PubMed ID: 10976558
[TBL] [Abstract][Full Text] [Related]
36. Long-term outcomes of intraoperative 5-fluorouracil versus intraoperative mitomycin C in primary trabeculectomy surgery.
Palanca-Capistrano AM; Hall J; Cantor LB; Morgan L; Hoop J; WuDunn D
Ophthalmology; 2009 Feb; 116(2):185-90. PubMed ID: 18930550
[TBL] [Abstract][Full Text] [Related]
37. PLGA-based drug delivery systems: importance of the type of drug and device geometry.
Klose D; Siepmann F; Elkharraz K; Siepmann J
Int J Pharm; 2008 Apr; 354(1-2):95-103. PubMed ID: 18055140
[TBL] [Abstract][Full Text] [Related]
38. Asymmetric biodegradable microdevices for cell-borne drug delivery.
Xia J; Wang Z; Huang D; Yan Y; Li Y; Guan J
ACS Appl Mater Interfaces; 2015 Mar; 7(11):6293-9. PubMed ID: 25751094
[TBL] [Abstract][Full Text] [Related]
39. Biocompatible polymer coating of titania nanotube arrays for improved drug elution and osteoblast adhesion.
Gulati K; Ramakrishnan S; Aw MS; Atkins GJ; Findlay DM; Losic D
Acta Biomater; 2012 Jan; 8(1):449-56. PubMed ID: 21930254
[TBL] [Abstract][Full Text] [Related]
40. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.
Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP
Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
